Clinical performance of fixed-pressure Sphera Duo (R) hydrocephalus shunt
Carregando...
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
ASSOC ARQUIVOS NEURO- PSIQUIATRIA
Autores
Citação
ARQUIVOS DE NEURO-PSIQUIATRIA, v.78, n.1, p.9-12, 2020
Resumo
Introduction: Cerebral hydrodynamics complications in shunted patients are due to the malfunction of the system. The objective of this retrospective, single-center, single-arm cohort study is to confirm the safety and performance of Sphera (R) Duo when used in adult patients suffering from hydrocephalus, pseudotumor cerebri or arachnoid cysts. Methods: Data were generated by reviewing 112 adult patient's charts, who were submitted to a ventriculoperitoneal shunt surgery and followed for one year after surgery. Results: The results show us that 76% of patients had their neurological symptoms improved and that the reoperation rate was 15% in the first year following surgery. Discussion: Sphera Duo (R) shunt system is an applicable shunt option in routine neurosurgical management of hydrocephalus by several causes. It has presented good results while mitigating effects of overdrainage. Overdrainage is especially important in adults with non-hypertensive hydrocephalus and can cause functional shunt failure, which causes subnormal ICP (particularly in the upright position) and is associated with characteristic neurological symptoms, such as postural headache and nausea. Conclusion: Sphera Duo (R) shunt system is safe when used in adult patients suffering from hydrocephalus, pseudotumor cerebri or arachnoid cyst.
Palavras-chave
ventriculoperitoneal shunt, complications, reoperation, outcome
Referências
- Agarwal N, 2019, J NEUROSURG, V130, P1252, DOI 10.3171/2017.11.JNS172212
- Benveniste RJ, 2018, J NEUROL SCI, V393, P105, DOI 10.1016/j.jns.2018.08.002
- Camacho EF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050708
- CHOUX M, 1992, J NEUROSURG, V77, P875, DOI 10.3171/jns.1992.77.6.0875
- de Oliveira MF, 2013, ARQ NEURO-PSIQUIAT, V71, P229, DOI 10.1590/0004-282X20130007
- de Oliveira MF, 2012, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00181
- Espay AJ, 2017, ANN NEUROL, V82, P503, DOI 10.1002/ana.25046
- Feletti A, 2019, OPER NEUROSURG, V17, P97, DOI 10.1093/ons/opy232
- Pinto FCG, 2014, WORLD J GASTRO ENDOS, V6, P415, DOI 10.4253/wjge.v6.i9.415
- Pinto FCG, 2013, NEUROSURGERY, V72, P845, DOI 10.1227/NEU.0b013e318285b37c
- Pinto FCG, 2012, ARQ NEURO-PSIQUIAT, V70, P704, DOI 10.1590/S0004-282X2012000900011
- Graff-Radford NR, 2016, NORMAL PRESSURE HYDR
- Grahnke K, 2018, WORLD NEUROSURG, V115, pE717, DOI 10.1016/j.wneu.2018.04.150
- Haridas AT, 2017, HYDROCEPHALUS CHILDR
- Junkkari A, 2017, EUR J NEUROL, V24, P58, DOI 10.1111/ene.13130
- McDowell MM, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e01099
- O'Kane MC, 1997, EUR J PEDIATR SURG, V7, P56
- Pereira RM, 2016, ARQ NEURO-PSIQUIAT, V74, P55, DOI 10.1590/0004-282X20150190
- Pinto FC, 2018, AUSTIN J SURG, V5, P1134